Study Stopped
The enrollment process is too difficult to complete
Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term
1 other identifier
interventional
5
1 country
1
Brief Summary
The purpose of this study is to determine amoxicillin is effective in the prevention of wound infection in normal labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedFirst Posted
Study publicly available on registry
May 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedDecember 3, 2015
December 1, 2015
1.5 years
April 28, 2014
December 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of perineal wound infection
Follow up perineal wound every day during admission and follow up 6 weeks after discharge
within 6 weeks after normal labor
Study Arms (2)
Amoxicillin
EXPERIMENTALThe patient will be received amoxicillin 500 mg 2 capsules orally bid pc for 5 days
Placebo
PLACEBO COMPARATORThe patient will be received placebo 2 capsules orally bid pc for 5 days
Interventions
The patient will be received amoxicillin 500 mg 2 capsules orally bid pc for 5 days
The patient will be received placebo 2 capsules orally bid pc for 5 days
Eligibility Criteria
You may qualify if:
- Term pregnancy
- Normal labor
You may not qualify if:
- Penicillin allergy
- Previous history antibiotic using within 2 weeks
- Patients cannot take oral medication
- Patients have underlying disease eg. diabetes mellitus, hypertension, HIV infection
- Premature rupture of membranes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Siriraj Hoapital Mahidol University
Bangkok, 10700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vitaya Titapant, MD
Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2014
First Posted
May 6, 2014
Study Start
May 1, 2014
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
December 3, 2015
Record last verified: 2015-12